Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Incyte stock hit 11% despite paediatric dermatology trials hitting target
Incyte’s stock price has taken a hit of more than 11%, despite two Phase III trials investigating its oral small-molecule JAK1 inhibitor in hidradenitis suppurativa (HS) hitting their pr...
Taiho outlays $1.14bn to acquire ADC specialist Araris
Taiho Pharmaceutical has agreed to acquire Swiss-based antibody-drug-conjugate (ADC) specialist Araris Biotech for up to $1.14bn, representing another big-dollar deal for the promising cancer ...
Cidara Therapeutics Announces Publication of CD388 Preclinical Data in Nature Microbiology
SAN DIEGO -- Cidara Therapeutics, Inc., a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced the publication ...
Unsafe and unregulated cell therapies being sold in Europe
The EMA warns of products being sold as dendritic cell therapies with little evidence, but high health risks, in the European Union.
Cannabis Terpenes Relieve Fibromyalgia Pain in Preclinical Models
Terpenes from the Cannabis sativa plant may be a viable medication for fibromyalgia and post-surgical pain relief, according to University of Arizona Health Sciences research published in Pharmacologi...
Mallinckrodt and Endo sign $6.7bn merger deal
Mallinckrodt Pharmaceuticals and Endo have agreed to merge in a $6.7bn deal, combining two pharmaceutical companies that recently emerged from bankruptcy proceedings tied to opioid litigation.
Epirium Bio to Present MF-300 Preclinical Data at the International Conference on Frailty and Sarcopenia Research
SAN DIEGO---Epirium Bio Inc. (Epirium), a clinical stage biopharmaceutical company advancing medicines for neuromuscular and fibrotic diseases, today announced the upcoming presentation of two...
EC approves Otsuka and Lundbeck’s Rxulti for schizophrenia
The European Commission (EC) has approved Otsuka Pharmaceutical and Lundbeck’s atypical oral antipsychotic Rxulti (brexpiprazole) for schizophrenia in adolescents aged 13 years and a...
Lundbeck’s amlenetug gains orphan drug status in Japan for MSA
Lundbeck has gained orphan drug designation (ODD) from Japan’s Ministry of Health, Labor and Welfare (MHLW) for amlenetug to treat multiple system atrophy (MSA).
Sun Pharma agrees to acquire Checkpoint Therapeutics
Sun Pharmaceutical Industries has agreed to acquire Checkpoint Therapeutics, a company specialising in immunotherapy and targeted oncology treatments, for an aggregate upfront price of $355m.
Polyrizon Initiates Preclinical Studies
Raanana, Israel, -- Polyrizon Ltd., a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced the initiation of preclinical studies for intranas...
Roche Genentech Innovation Center Boston Launched at Harvard’s Enterprise Research Campus
The Roche Genentech Innovation Center Boston has been launched at Harvard’s Enterprise Research Campus in Allston, MA.
53
54
55
56
57
58
59
60
61
